Prevalence and burden of breathlessness in patients with chronic obstructive pulmonary disease managed in primary care

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Müllerová, Hana ^a   Lu, Chao ^b   Li, Hao ^b   Tabberer, Maggie ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; CONSULTATION; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HIGH RISK PATIENT; HUMAN; MALE; MEDICAL HISTORY; OBESITY; PREVALENCE; PRIMARY MEDICAL CARE; RISK FACTOR; SEX DIFFERENCE;

AGED; COHORT STUDIES; DATABASES, FACTUAL; DYSPNEA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATIENT OUTCOME ASSESSMENT; PREVALENCE; PRIMARY HEALTH CARE; PUBLIC HEALTH SURVEILLANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84897532747     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085540     Document Type: Article

References (42)

1. rd December 2012.
2. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, et al. (1999) Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54(7): 581-586. (Pubitemid 29296676)
3. Sarkar S, Amelung PJ (2006) Evaluation of the dyspneic patient in the office. Prim Care 33(3): 643-657. (Pubitemid 44679783)
4. Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, et al. (2012) An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 185(4): 435-452.
5. Jolley CJ, Moxham J (2009) A physiological model of patient-reported breathlessness during daily activities in COPD. Eur Respir Rev 18(112): 66-79.
6. Booth S, Bausewein C, Higginson I, Moosavi SH (2009) Pharmacological treatment of refractory breathlessness. Expert Rev Respir Med 3(1): 21-36.
7. Burgel PR, Escamilla R, Perez T, Carre P, Caillaud D, et al. (2012) Impact of comorbidities on COPD-specific health-related quality of life. Respir Med [Epub ahead of print].
8. Dransfield MT, Bailey W, Crater G, Emmett A, O'Dell DM, et al. (2011) Disease severity and symptoms among patients receiving monotherapy for COPD. Prim Care Respir J 20(1): 46-53.
9. Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, et al. (2011) Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J 38(1): 29-35.
10. Walke LM, Byers AL, Tinetti ME, Dubin JA, McCorkle R, et al. (2007) Range and severity of symptoms over time among older adults with chronic obstructive pulmonary disease and heart failure. Arch Intern Med 167(22): 2503-2508. (Pubitemid 350254911)
11. Howard K, Berry P, Petrillo J, Wiklund I, Roberts L, et al. (2012) Development of the Shortness of Breath with Daily Activities Questionnaire (SOBDA). Value Health 15(8): 1042-1050.
12. Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, et al. (2011) Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med 105(1): 57-66.
13. Mahler DA, Ward J, Waterman LA, Baird JC. (2012) Longitudinal changes in patient-reported dyspnea in patients with COPD. COPD 2012 9(5): 522-527.
14. Figarska SM, Boezen HM, Vonk JM. (2012) Dyspnea severity, changes in dyspnea status and mortality in the general population: the Vlagtwedde/ Vlaardingen study. Eur J Epidemiol 27(11): 867-876.
15. Bausewein C, Farquhar M, Booth S, Gysels M, Higginson IJ. (2007) Measurement of breathlessness in advanced disease: a systematic review. Respir Med 101(3): 399-410. (Pubitemid 46205909)
16. Fletcher C, lmes P, Fairbairn A, Wood C. (1959) The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 2(5147): 257-266.
17. Jones P, Miravitlles M, van der Molen T, Kulich K. (2012) Beyond FEV(1) in COPD: a review of patient-reported outcomes and their measurement. Int J Chron Obstruct Pulmon Dis 7: 697-709.
18. Rennard S, Decramer M, Calverley PM, Pride NB, Soriano JB, et al. (2002) Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J 20(4): 799-805. (Pubitemid 35175112)
19. Uzaslan E, Mahboub B, Beji M, Nejjari C, Tageldin MA, et al. (2012) The burden of chronic obstructive pulmonary disease in the Middle East and North Africa: results of the BREATHE study. Respir Med 106 Suppl 2: S45-S59.
20. Zhong N, Wang C, Yao W, Chen P, Kang J, et al. (2007) Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med 176(8): 753-760. (Pubitemid 47598476)
21. NICE. (2011) Management of chronic obstructive pulmonary disease in adults in primary and secondary care (partial update). Available: http://www.nice.org.uk/nicemedia/live/13029/49397/49397.pdf Accessed: 3rd December 2012.
22. NHS Employers. (2009)Quality and outcomes framework guidance for GMS contract 2009/10. Available: http://www.nhsemployers.org/aboutus/publications/ documents/qof-guidance-2009-final.pdf. Accessed 3rd December 2012.
23. Chronic Obstructive Pulmonary Disease. (2004) National clinical guidelines and management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 59: Suppl 1.
24. NICE. (2007) MRC dyspnoea scale. Available: http://www.nice.org.uk/ usingguidance/commissioningguides/ pulmonaryrehabilitationserviceforpatientswithcopd/mrc-dyspnoea-scale.jsp. Accessed 10th January 2013.
25. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, et al. (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176(6): 532-555. (Pubitemid 47403272)
26. Khan NF, Perera R, Harper S, Rose PW. (2010) Adaptation and validation of the Charlson Index for Read/OXMIS coded databases. BMC Fam Pract 11: 1.
27. O'Donnell DE, Banzett RB, Carrieri-Kohlman V, Casaburi R, Davenport PW, et al. (2007) Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proc Am Thorac Soc 4(2): 145-168. (Pubitemid 46743309)
28. Redelmeier DA, Goldstein RS, Min ST, Hyland RH. (1996) Spirometry and dyspnea in patients with COPD. When small differences mean little. Chest 109(5): 1163-1168. (Pubitemid 26145650)
29. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, et al. (2007) Longitudinal deteriorations in patient reported outcomes in patients with COPD. Respir Med 101(1): 146-153. (Pubitemid 44841779)
30. O'Donnell DE, Laveneziana P. (2007) Dyspnea and activity limitation in COPD: mechanical factors. COPD 4(3): 225-236. (Pubitemid 47345897)
31. Ora J, Jensen D, O'Donnell DE. (2010) Exertional dyspnea in chronic obstructive pulmonary disease: mechanisms and treatment approaches. Curr Opin Pulm Med 16(2): 144-149.
32. O'Donnell DE, Ora J, Webb KA, Laveneziana P, Jensen D. (2009) Mechanisms of activity-related dyspnea in pulmonary diseases. Respir Physiol Neurobiol 167(1): 116-132.
33. Laveneziana P, Palange P, Ora J, Martolini D, O'Donnell DE. (2009) Bronchodilator effect on ventilatory, pulmonary gas exchange, and heart rate kinetics during high-intensity exercise in COPD. Eur J Appl Physiol 107(6): 633-643.
34. O'Donnell DE. (2006) Physiology and consequences of lung hyperinflation in COPD. Laveneziana P, editor. 100. Eur. Respir. Rev. 15, 61-67.
35. O'Donnell DE, Revill SM, Webb KA. (2001) Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164(5): 770-777. (Pubitemid 32881912)
36. Sheel AW, Foster GE, Romer LM. (2011) Exercise and its impact on dyspnea. Curr Opin Pharmacol 11(3): 195-203.
37. Sahebjami H. (2000) Influence of body weight on the severity of dyspnea in chronic obstructive pulmonary disease. Sathianpitayakul E., editor. Am J Respir Crit Care Med 161[3 Pt 1], 886-890.
38. Lange P, Marott JL, Vestbo J, Olsen KR, Ingebrigtsen TS, et al. (2012) Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med 186(10): 975-981.
39. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. (2002) Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 57(10): 847-852. (Pubitemid 35178607)
40. Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, et al. (2010) Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363(12): 1128-1138.
41. Soriano JB, Maier WC, Visick G, Pride NB. (2001) Validation of general practitioner-diagnosed COPD in the UK General Practice Research Database. Eur J Epidemiol 17(12): 1075-1080.
42. Strong M, South G, Carlisle R. (2009) The UK Quality and Outcomes Framework pay-for-performance scheme and spirometry: rewarding quality or just quantity? A cross-sectional study in Rotherham, UK. BMC Health Serv Res 9: 108.